Holomic CEO, Dr. Neven Karlovac Selected for Adaptive Business Leaders (ABL) 14th Innovations In Healthcare ABBY Award

Holomic CEO,Neven Karlovac, has been selected for the Adaptive Business Leaders (ABL) Organization  14th Innovations In HealthcareSM ABBY Award that is recognizing five new programs and products that promise to lower the cost of quality healthcare.

ABL, California’s leading Chief Executives’ Organization since 1983, provides its Members with executive leadership development and executive business coaching through its confidential peer CEO Advisory Board Round Tables and executive learning workshops, network of CEO peers and expert resources. ABL supports the needs of its Member CEOs by providing a place for top-level executives of publicly traded, private and not-for-profit companies to draw on the experience, knowledge and skill sets of their peers in a non-competing vertical industry personal advisory board – multi-coach approach – setting.

This year, ABL’s 14th Innovation in HealthcareSM ABBY Awards event, will honor a “crowd-solver,” provider, health IT and medical technologists, and a government program, that have overcome impressive obstacles to make their healthcare innovations realities.

Founded in 2011, as a spinoff from Dr. Aydogan Ozcan’s research lab at UCLA, Holomic LLC has been commercializing biophotonics technologies emerging from the lab to transform point-of-care diagnostics and healthcare delivery globally. Among Holomic’s product offering is the recently launched rapid diagnostic test reader, the HRDR-200, enabling more reliable quantitative lateral flow immunoassay tests, instant access to electronic health records, and real-time, wide-area diagnostic data collection. The device is ideal for point-of-care, telemedicine, and public health monitoring.